Amkor Technology (NASDAQ: AMKR) CEO logs 10,000-share sale under 10b5-1 plan
Rhea-AI Filing Summary
Amkor Technology, Inc. reports that its President and CEO, who is also a Director, executed a planned stock sale. On 12/15/2025, the reporting person sold 10,000 shares of Amkor common stock at a weighted average price of $44.80 per share, as disclosed in Table I. This transaction was carried out under a Rule 10b5-1 trading plan adopted on June 6, 2025, meaning the sale followed a pre-established schedule rather than being made at the insider’s discretion at the time of sale.
After this transaction, the reporting person beneficially owns 336,699 shares of Amkor common stock in direct form. The filing notes that the actual sales occurred in multiple trades at prices ranging from $44.37 to $45.18 per share, and the insider has undertaken to provide detailed breakdowns of the share amounts at each price upon request.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 10,000 | $44.80 | $448K |
Footnotes (1)
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 06, 2025. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $44.37 to $45.18. The Reporting Person hereby undertakes to provide, upon request, to the staff of the Securities and Exchange Commission, Amkor Technology, Inc. (the "Issuer"), or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
FAQ
What insider transaction did Amkor Technology (AMKR) report in this Form 4?
The President and CEO, who is also a Director, reported selling 10,000 shares of Amkor Technology common stock on 12/15/2025 at a weighted average price of $44.80 per share.
Was the AMKR CEO’s stock sale under a Rule 10b5-1 trading plan?
Yes. The filing states the sale was effected pursuant to a Rule 10b5-1 trading plan that the reporting person adopted on June 06, 2025.
Who signed the AMKR Form 4 for this insider transaction?
The Form 4 was signed by /s/ Mark N. Rogers as Attorney-in-Fact for Guillaume Marie Jean Rutten, the reporting person.